AZD0780
AZD0780 (EX-A6975) is an oral small molecule PCSK9 inhibitor being developed by AstraZeneca as a first-in-class treatment for patients with dyslipidemia that is uncontrolled with statins alone.
Product Specifications
CAS Number
2455427-91-3
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
414.41
Molecular Formula
C20H20F2N6O2
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV703446 1.0 µg DNA
FBXO32 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)
Sign In for Pricing
View Details 
TRV-0006351 5x 10^5 Cells
Primary Rabbit Esophageal Epithelial Cells (EEC)
Sign In for Pricing
View Details 
K1039302 1.0 µg DNA
IGHV3-48 sgRNA CRISPR Lentivector (Human) (Target 1)
Sign In for Pricing
View Details RD-CARNS1-Mu-48Tests 48 Tests
Mouse Carnosine Synthase 1 (CARNS1) ELISA Kit
Sign In for Pricing
View Details